NCT06368934View on ClinicalTrials.gov

Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma

NANot yet recruitingINTERVENTIONAL

Enrollment

326

Participants

Timeline

Start Date

April 8, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

GliomaGlioblastoma

Interventions

PROCEDURE

sub-lobectomy

Combined with previous research and our team's precise neurosurgery concept, we define the surgical strategy based on lobectomy and further preserving the brain parenchyma in functional areas according to anatomical landmarks and electrophysiological boundaries as sub-lobectomy.

PROCEDURE

imaging total resection

Imaging total resection (T1-enhanced borders) will met the RANO criteria

Trial Locations (1)

200040

Hushan Hospital, Fudan University, Shanghai

All Listed Sponsors

lead

Huashan Hospital

OTHER

NCT06368934 - Sub-lobectomy for IDH Wild-type and TERT Promoter Mutant Glioblastoma | Biotech Hunter | Biotech Hunter